Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2015 08:00 ET | Source: Macrocure

Macrocure to Host and Webcast Analyst & Investor Day on February 12, 2015

Company to Provide Comprehensive Review of Mechanism of Action Study Results and Patient Case Studies Five Physicians to Present and Host Question and Answer Session PETACH TIKVA, Israel, Jan....
December 15, 2014 08:00 ET | Source: Macrocure

Macrocure Ltd. Featured in Five News Outlets

PETACH TIKVA, Israel, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
December 11, 2014 07:00 ET | Source: Macrocure

Macrocure Announces Completion of Mechanism of Action Study

PETACH TIKVA, Israel, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
December 01, 2014 08:00 ET | Source: Macrocure

Macrocure Ltd. to Present at Upcoming Oppenheimer Healthcare Conference

PETACH TIKVA, Israel, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
November 25, 2014 08:00 ET | Source: Macrocure

Macrocure Announces Special General Meeting of Shareholders for Approval of Compensation Policy

PETACH TIKVA, Israel, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
November 03, 2014 16:05 ET | Source: Macrocure

Macrocure Ltd. Announces Third Quarter 2014 Financial Results

Completed patient enrollment in Pivotal, Phase III Diabetic Foot Ulcer clinical trial Pivotal, Phase III Venous Leg Ulcerclinical trial is showing strong recruitment rates PETACH TIKVA, Israel,...
October 21, 2014 08:00 ET | Source: Macrocure

Macrocure Ltd Announces Third Quarter 2014 Financial Results Date and Conference Call

PETACH TIKVA, Israel, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
October 16, 2014 08:00 ET | Source: Macrocure

Macrocure Ltd. to Present at Upcoming Nomura, Credit Suisse and Jefferies Health Care Conferences in November

PETACH TIKVA, Israel, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
October 01, 2014 10:15 ET | Source: Macrocure

Macrocure Nominates Katherine Wolf and Yuval Yanai for Election to Board of Directors and Announces Special General Meeting of Shareholders

PETACH TIKVA, Israel, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
September 02, 2014 11:25 ET | Source: Macrocure

Macrocure Ltd. Completes Enrollment in Pivotal Phase III Clinical Trial of CureXcell in Diabetic Foot Ulcers

PETACH TIKVA, Israel, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...